STAAR Surgical Return on Tangible Equity 2010-2023 | STAA

Current and historical return on tangible equity values for STAAR Surgical (STAA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
STAAR Surgical Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $0.02B $0.38B 6.07%
2023-09-30 $0.02B $0.38B 6.00%
2023-06-30 $0.03B $0.35B 7.76%
2023-03-31 $0.03B $0.34B 10.26%
2022-12-31 $0.04B $0.33B 13.08%
2022-09-30 $0.04B $0.32B 14.31%
2022-06-30 $0.04B $0.30B 13.77%
2022-03-31 $0.03B $0.27B 13.06%
2021-12-31 $0.03B $0.26B 11.80%
2021-09-30 $0.02B $0.25B 10.37%
2021-06-30 $0.02B $0.23B 10.19%
2021-03-31 $0.01B $0.21B 5.76%
2020-12-31 $0.01B $0.20B 3.36%
2020-09-30 $0.01B $0.18B 5.31%
2020-06-30 $0.01B $0.17B 4.37%
2020-03-31 $0.01B $0.16B 7.87%
2019-12-31 $0.01B $0.16B 8.93%
2019-09-30 $0.01B $0.15B 5.78%
2019-06-30 $0.01B $0.14B 5.24%
2019-03-31 $0.01B $0.14B 4.54%
2018-12-31 $0.01B $0.13B 5.71%
2018-09-30 $0.00B $0.13B 6.13%
2018-06-30 $0.00B $0.05B 9.25%
2018-03-31 $0.00B $0.04B 2.50%
2017-12-31 $-0.00B $0.04B -5.30%
2017-09-30 $-0.00B $0.04B -5.48%
2017-06-30 $-0.01B $0.04B -14.08%
2017-03-31 $-0.01B $0.04B -16.90%
2016-12-31 $-0.01B $0.04B -33.57%
2016-09-30 $-0.01B $0.04B -36.36%
2016-06-30 $-0.01B $0.04B -35.86%
2016-03-31 $-0.01B $0.04B -35.62%
2015-12-31 $-0.01B $0.04B -19.44%
2015-09-30 $-0.01B $0.04B -25.35%
2015-06-30 $-0.01B $0.04B -27.97%
2015-03-31 $-0.01B $0.03B -27.59%
2014-12-31 $-0.01B $0.03B -24.16%
2014-09-30 $-0.01B $0.04B -18.54%
2014-06-30 $-0.00B $0.04B -8.16%
2014-03-31 $-0.00B $0.04B -2.88%
2013-12-31 $0.00B $0.04B 0.00%
2013-09-30 $0.00B $0.03B 0.00%
2013-06-30 $-0.00B $0.03B -3.45%
2013-03-31 $-0.00B $0.03B -3.57%
2012-12-31 $-0.00B $0.03B -3.67%
2012-09-30 $0.00B $0.03B 0.00%
2012-06-30 $0.00B $0.03B 0.00%
2012-03-31 $0.00B $0.03B 4.26%
2011-12-31 $0.00B $0.03B 4.65%
2011-09-30 $0.00B $0.02B 0.00%
2011-06-30 $-0.00B $0.02B -5.63%
2011-03-31 $-0.00B $0.02B -23.88%
2010-12-31 $0.00B $0.02B 0.00%
2010-09-30 $0.00B $0.02B 0.00%
2010-06-30 $-0.00B $0.02B -7.69%
2010-03-31 $0.00B $0.02B 0.00%
2009-12-31 $-0.01B $0.01B -75.00%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.521B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
West Pharmaceutical Services (WST) United States $28.373B 47.97
Cardinal Health (CAH) United States $25.885B 15.56
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Labcorp (LH) United States $17.372B 14.84
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
Merit Medical Systems (MMSI) United States $4.272B 24.44
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00